Wei Wei

机构：Dalian Medical University, Anhui Medical University, Yale Cancer Center, Yale University, First Affiliated Hospital of Anhui Medical University, First Affiliated Hospital of Dalian Medical University, First Affiliated Hospital of Wannan Medical College · ORCID：0000-0002-0960-7269

发表论文 447 篇 · 总被引 8043 次 · h-index 39

代表论文

Phase II Trial of Chemotherapy, Cetuximab, and Erlotinib in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck (2025 · Head & Neck · 被引 6)
Neutrophil Extracellular Traps Enhance Procoagulant Activity and Predict Poor Prognosis in Patients With Metastatic Breast Cancer (2025 · International Journal of General Medicine · 被引 5)
Neoadjuvant Chemotherapy is Associated with Worse 5-Year Overall Survival in Patients with Metaplastic Breast Cancer Compared with Primary Surgery: A National Cancer Database Analysis (2025 · Annals of Surgical Oncology · 被引 2)
Fruquintinib in less pretreated patients: Multivariate profile-matching analysis of FRESCO-2 to FRESCO (2025 · European Journal of Cancer · 被引 2)
Phase 2 trial of dual EGFR inhibition with cetuximab and afatinib in patients with recurrent/metastatic head and neck squamous cell cancers (HNSCC). (2025 · Journal of Clinical Oncology · 被引 2)
First mammogram-detected cancers portend worse survival in young women diagnosed with breast cancer (2025 · Breast Cancer Research and Treatment · 被引 2)